Is RadNet, Inc. (RDNT) A Good Stock To Buy Now?

Is RDNT a bully banal to buy? We came crossed a bearish thesis connected RadNet, Inc. connected Hunterbrook’s Substack. In this article, we volition summarize the bears’ thesis connected RDNT. RadNet, Inc.'s stock was trading astatine $57.85 arsenic of April 20th. RDNT’s trailing P/E was 386.89 according to Yahoo Finance.

hin255/Shutterstock.com

RadNet, Inc., unneurotic with its subsidiaries, provides outpatient diagnostic imaging services successful the United States and internationally. RDNT faces increasing skepticism pursuing caller disclosures and investigative reporting that rise questions astir the integrity of its fiscal reporting. The company, which has repositioned itself arsenic an AI-driven maturation story, has softly eliminated “same-center” income metrics from its 2025 10-K, a cardinal show indicator that Wall Street historically cited to gauge integrated growth.

Read More: 15 AI Stocks That Are Quietly Making Investors Rich

Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential

Hunterbrook Media’s probe highlighted that RadNet had been consolidating adjacent imaging centers, artificially inflating same-center maturation to look betwixt 6% and 10%, erstwhile the underlying integrated maturation was person to 2.5%–3%. Multiple erstwhile accounting employees described a civilization of unit and top-down manipulation, wherever adjustments were made to contiguous a much favorable fiscal picture, often bypassing modular controls and nonrecreational judgment.

Leadership reportedly prioritized optics implicit accuracy, with practices specified arsenic capitalizing expenses to boost assets and obscure existent profitability. Despite these reddish flags, RadNet’s absorption maintains that its GAAP gross is accurate, yet the removal of elaborate metrics makes it hard for investors to independently verify performance. The Digital Health division, cardinal to the company’s AI rebrand, generated little than 5% of full gross successful 2025, calling into question the rationale down the elevated valuation multiples present assigned to the business.

Trading astatine astir 18 times EBITDA and higher erstwhile adjustments are considered, RadNet’s banal appears richly priced comparative to the underlying fundamentals, peculiarly fixed the opaque reporting, humanities accounting irregularities, and constricted visibility into integrated growth. These factors suggest a cautious oregon bearish stance, arsenic the marketplace whitethorn person overestimated the company’s AI-driven maturation imaginable portion underestimating operational and fiscal risks.

Previously, we covered a bullish thesis connected Tenet Healthcare Corporation (THC) by BlackSwanInvestor successful December 2024, which highlighted the company’s absorption connected high-margin Ambulatory Care growth, improved currency flow, indebtedness reduction, and operational efficiency, with THC’s banal trading astatine a important discount to intrinsic value. THC’s banal terms has appreciated by astir 52.15% since our coverage. Hunterbrook shares a contrarian presumption connected RadNet, Inc. (RDNT), emphasizing accounting irregularities, opaque same-center maturation metrics, and elevated valuation multiples, suggesting caution contempt its AI maturation narrative.